Editorial Board
Senior Editor
- Donald G. Phinney, PhD, University of Florida, Scripps Biomedical Research, Gainesville, Florida, United States of America
Commissioning Editor
- Patrick J. Hanley, PhD, Children's National Hospital, Washington, District of Columbia, United States of America
Associate Editors
- Oscar Lee, MD, PhD, National Yang Ming Chiao Tung University - Yangming Campus, Taipei, Taiwan
- Anna Pasetto, PhD, Karolinska Institute, Department of Laboratory Medicine, Huddinge, Sweden
- Susan Prockop, MD, Boston Children's Hospital, Boston, Massachusetts, United States of America
- Qasim A. Rafiq, University College London, Department of Biochemical Engineering, London, United Kingdom
- Sowmya Viswanathan, PhD, University Health Network, Toronto, Ontario, Canada
Assistant Editor
- Rachel Burga, PhD, Obsidian Therapeutics, Inc., Cambridge, Massachusetts, United States of America
Program Management Senior Coordinator
- Felix Grignon, International Society for Cellular Therapy, Vancouver, British Columbia, Canadaemail: felix@isctglobal.org
Editorial Board
- Alice Bertaina, MD, PhD, Stanford University, Stanford, California, United States of America
- Jaap Boelens, MD, PhD, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America
- Vincenzo Cardinale, MD, PhD, University of Rome La Sapienza, Roma, Italy
- Rachele Ciccocioppo, MD, A.O.U.I. Policlinico G.B. Rossi and University of Verona, Verona, Italy
- Nancy H. Collins, PhD, Foundation for the Accreditation of Cellular Therapy FACT, Darien, Connecticut, United States of America
- Patrizia Comoli, PhD, Foundation IRCCS Polyclinic San Matteo Cell Factory Pediatric Hematology Oncology Unit, Pavia, Italy
- Charles Cox Jr., MD, University of Texas Medical School, Houston, Texas, United States of America
- Natividad Cuende, MD, MPH, PhD, Andalusian Transplant Coordination, Andalusia, Spain
- Wanxing Cui, MD, PhD, MedStar Georgetown University Hospital, Washington, District of Columbia, United States of America
- Colleen Delaney, MD, MSC, Nohla Therapeutics, Research & Development, Seattle, Washington, United States of America
- Ekaterina Doubrovina, MD, PhD, Memorial Sloan-Kettering Cancer Center, Department of Pediatrics, New York, New York, United States of America
- Allen Eaves, MD, PhD, FRCPC, STEMCELL Technologies Inc, Vancouver, British Columbia, Canada
- J.H.F. Falkenburg, MD, PhD, Leiden University Medical Center, Department of Hematology, Leiden, Netherlands
- Miguel Forte, MD, PhD, Bone Therapeutics SA, Gosselies, Belgium
- Jacques Galipeau, MD, FRCP©, University of Wisconsin-Madison, Department of Medicine, Madison, Wisconsin, United States of America
- Damián García-Olmo, MD, PhD, Autonomous University of Madrid, Madrid, Spain
- Adrian Gee, PhD, Baylor College of Medicine Center for Cell and Gene Therapy,
- Bernd Giebel, PhD, University Hospital Essen, Essen, Germany
- Massimiliano Gnecchi, MD, PhD, University of Pavia & IRCCS Policlinico San Matteo, Pavia, Italy
- David Gottlieb, MBBS, FRACP, FRCPA, MD, Westmead Hospital Bone Marrow Transplant & Cell Therapies Group, Westmead, New South Wales, Australia
- Michael Gustafson, PhD, Mayo Clinic Hospital, Phoenix, Arizona, United States of America
- Shelly Heimfeld, PhD, Fred Hutchinson Cancer Research Center Clinical Research Division, Seattle, Washington, United States of America
- Christian Jorgensen, MD, PhD, Institute for Research in Biotherapy, Montpellier, France
- Joanne Kurtzberg, MD, Duke University, Department of Pediatrics, Durham, North Carolina, United States of America
- Ping Law, PhD, Miltenyi Biotec BV & Co KG, Bergisch Gladbach, Germany
- Bruce Levine, PhD, Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America
- Rebecca Lim, PhD, Hudson Institute of Medical Research, Clayton, Australia
- Sai-Kiang Lim, PhD, A*STAR Institute of Medical Biology, Singapore, Singapore
- Douglas W. Losordo, MD, Caladrius Biosciences, New York, New York, United States of America
- Mark W. Lowdell, PhD, FRCPath, FRSB, University College London Institute of Immunity and Transplantation, London, United Kingdom
- Ivan Martin, PhD, University Hospital Basel, Basel, Switzerland
- Robert W. Mays, PhD, Athersys, Inc., Department of Regenerative Medicine, Cleveland, Ohio, United States of America
- Richard T. Maziarz, MD, Oregon Health & Science University, Adult Blood and Marrow Stem Cell Transplant Program, Portland, Oregon, United States of America
- David H. McKenna, MD, University of Minnesota Medical School, Molecular and Cellular Therapeutics, Minneapolis, Minnesota, United States of America
- Ian McNiece, PhD, Biocardia Inc, Miami, Florida, United States of America
- J. Joseph Melenhorst, PhD, University of Pennsylvania, Department of Pathology and Laboratory Medicine, Philadelphia, Pennsylvania, United States of America
- Jeffrey J. Molldrem, MD, University of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, Texas, United States of America
- George F. Muschler, MD, Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, Ohio, United States of America
- Robert Nordon, MB, BS, BMedSci, PhD, University of Technology Sydney, Faculty of Engineering and Information Technology, Broadway, Australia
- Giuseppe Orlando, MD, PhD, Wake Forest University, Department of General Surgery, Winston-Salem, North Carolina, United States of America
- Josef Priller, MD, Department of Neuropsychiatry and Laboratory of Molecular Psychiatry, Charité - University Medicine Berlin, Berlin, Germany
- Claudia Rossig, MD, University Children's Hospital Muenster, Pediatric Hematology and Oncology, Muenster, Germany
- Fermin Sanchez-Guijo, MD, PhD, Institute for Biomedical Research of Salamanca, Salamanca, Spain
- Khalid Shah, MS, PhD, Harvard Medical School, Boston, Massachusetts, United States of America
- Warren Sherman, MD, FACC, Cardiovascular Biotherapeutics Inc Dallas Office, Dallas, Texas, United States of America
- Akihiro Shimosaka, PhD, Research Foundation for Community Medicine, Tokyo, Japan
- Elizabeth J. Shpall, MD, University of Texas MD Anderson Cancer Center, Department Stem Cell Transplantation and Cellular Therapy, Houston, Texas, United States of America
- Sandeep Soni, MD, CRISPR Therapeutics, San Francisco, California, United States of America
- Paul Szabolcs, MD, Children's Hospital of Pittsburgh of UPMC, Department of Pediatrics, Pittsburgh, Pennsylvania, United States of America
- Satoshi Takahashi, MD, PhD, The University of Tokyo Institute of Medical Science Advanced Clinical Research Center, Tokyo, Japan
- Torsten Tonn, MD, PhD, Dresden University Hospital, Dresden, Germany
- Frits Van Rhee, MD, PhD, MRCP (UK), FRCPath, FACP, UAMS Myeloma Center, Little Rock, Arkansas, United States of America
- Dominic Wall, PhD, Cell Therapies PTY Ltd, Melbourne, Victoria, Australia
- Daniel J. Weiss, MD, PhD, University of Vermont Larner College of Medicine, Burlington, Vermont, United States of America
- Joseph C. Wu, MD, PhD, Stanford Cardiovascular Institute, Stanford, California, United States of America
